• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Recent Advances in the Study of 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl- (CAS: 58324-90-6)

The compound 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl- (CAS: 58324-90-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This bicyclic amine derivative, characterized by its unique structural framework, has shown promising potential in various applications, including drug development, catalysis, and material science. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its synthesis, properties, and potential applications.

Recent studies have focused on optimizing the synthesis of 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl-, with particular emphasis on improving yield and purity. A novel catalytic approach utilizing palladium-based catalysts has been reported to enhance the efficiency of the dibutylation process, resulting in higher yields under milder reaction conditions. This advancement is expected to facilitate the large-scale production of the compound for further research and industrial applications.

In the realm of drug discovery, 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl- has been investigated for its potential as a scaffold for designing new therapeutic agents. Computational studies have revealed that the compound's rigid bicyclic structure and the presence of nitrogen atoms make it an excellent candidate for binding to various biological targets. Preliminary in vitro assays have demonstrated moderate activity against certain enzyme systems, suggesting its utility in developing enzyme inhibitors.

Furthermore, the compound's physicochemical properties, including its solubility and stability, have been characterized in detail. Researchers have found that 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl- exhibits good solubility in organic solvents, which is advantageous for its use in synthetic chemistry. Stability studies under various pH conditions have also been conducted, providing valuable data for its potential formulation in pharmaceutical products.

Another area of interest is the application of 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl- in material science. Its ability to act as a ligand in coordination chemistry has been explored, with promising results in the development of new metal-organic frameworks (MOFs). These MOFs exhibit unique properties, such as high porosity and thermal stability, making them suitable for gas storage and separation technologies.

In conclusion, the recent research on 3,7-Diazabicyclo[3.3.1]nonane, 3,7-dibutyl- (CAS: 58324-90-6) underscores its versatility and potential across multiple scientific disciplines. Continued investigation into its synthesis, properties, and applications is expected to yield further breakthroughs, particularly in drug development and material science. The compound's unique structural features and functional groups position it as a valuable building block for future innovations in chemical biology and pharmaceutical research.

• 58324-99-5(3,7-Diazabicyclo[3.3.1]nonane, 3-methyl-)
• 90203-05-7(N,N-Dimethyl-1-piperidin-3-ylmethanamine)
• 724695-93-6(4,4-Piperidinedimethanamine,1-methyl-(9CI))
• 14613-37-7((1-methyl-3-piperidyl)methanamine)
• 14156-91-3(3-(3-Methylpiperidin-1-yl)propan-1-amine)
• 6238-38-6(1-Azabicyclo[2.2.2]octane-3-methanamine,N,N-dimethyl-)
• 909037-18-9(3,7-Dipropyl-3,7-diazabicyclo[3.3.1]nonane)
• 14789-33-4(3,7-Diazabicyclo[3.3.1]nonane,3,7-dimethyl-)
• 254905-65-2((R)-N,N-Dimethyl-1-(piperidin-3-yl)methanamine)
• 120990-84-3(Diethyl-piperidin-3-ylmethyl-amine)